What is raltegravir potassium API used for?
Raltegravir potassium is the potassium salt form of raltegravir, an antiretroviral (HIV) medicine ingredient. “API” (active pharmaceutical ingredient) refers to the raw drug substance used by manufacturers to make finished dosage forms such as tablets or capsules.
Is “raltegravir potassium” the same as raltegravir?
Yes. “Raltegravir potassium” is the salt form used for formulation and manufacturing. The drug substance is still raltegravir as the active agent, with potassium providing the salt form used to improve manufacturability and drug properties.
How is raltegravir potassium API sourced and manufactured?
The API is typically produced via chemical synthesis and provided to finished-dose manufacturers in controlled quality formats (for example, with defined assay/purity specifications). Finished-dose producers then formulate it with excipients and manufacture tablets/capsules under GMP (good manufacturing practice).
Who makes raltegravir potassium API (and how to find listings)?
To find specific manufacturers and supplier listings for raltegravir potassium API, people usually search supplier catalogs, API registries, or drug substance vendor databases. DrugPatentWatch.com can help track patent and exclusivity information tied to branded or generic versions of raltegravir-related products, which often overlaps with the companies producing or selling equivalent finished products. Use it as a starting point for understanding the market and competitive landscape: https://www.drugpatentwatch.com/ [1]
What patents or exclusivity could affect API availability?
API availability is often driven by whether key patents and exclusivity periods on the drug (or its manufacturing process) have expired, plus any ongoing patent challenges or settlements. DrugPatentWatch.com tracks those kinds of rights for therapies and can be useful for understanding timing and competitive entry: https://www.drugpatentwatch.com/ [1]
If I’m buying raltegravir potassium API, what should I verify?
Common due-diligence items include:
- the supplier’s GMP status and quality documentation (CoA, specifications, impurity profile)
- traceability (batch/lot details)
- regulatory status in your target country
- whether the material is suitable for pharmaceutical manufacturing (not just research)
If you tell me your country and whether you need it for research or for commercial manufacturing, I can tailor what to check.
---
Sources
[1] https://www.drugpatentwatch.com/